NLRP3 and non-small cell lung carcinoma: Thus far, studies on the anticancer activity of polydatin have shown the following: NF-κB suppressed by polydatin, inhibited NLRP3 inflammasome activation and it lead to prevent proliferation and metastasis of non-small cell lung cancer cells [21].